Publications

5674 Results

Prostate-specific antigen and its role on the Prostate Cancer Prevention Trial

Authors
CM Tangen;PJ Goodman
Journal / Conference
Prostate Cancer Screening, 2nd edition, D. Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 24, pp. 333-348
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator

Authors
DP Ankerst;IM Thompson
Journal / Conference
Prostate Cancer Screening, 2nd edition, DP Ankerst, IM Thompson, C Tangen, Eds., Humana Press, New York, Ch. 12, pp. 195-203.
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

The performance characteristics of prostate-specific antigen for prostate cancer screening

Authors
IM Thompson;DP Ankerst
Journal / Conference
Prostate Cancer Screening, 2nd editiion, DP Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 6, pp. 61-70
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Selenium and vitamin E: interesting biology and dashed hope. PMID: 19244172

Authors
EA Klein
Journal / Conference
Journal of the National Cancer Institute 101(5):283-295
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention. PMID: 19213568

Authors
BK Dunn;A Ryan;L Ford
Journal / Conference
Recent Results in Cancer Research 181:183-193
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Fc gamma receptor 3a genotype predicts overall survival for follicular lymphoma patients treated on Southwest Oncology Group trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Authors
DO Persky;D Dornan;B Goldman;M LeBlanc;RM Braziel;RI Fisher;D Maloney;T Miller;OW Press;LM Rimsza
Journal / Conference
Blood 114:abst.#111 (ASH Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9800, S9911

Accurate classification of diffuse large cell lymphoma into germinal center and activated B cell subtypes using a nuclease protection assay on formalin fixed paraffin embedded: a study from the Lymphoma and Leukemia Molecular Profiling Project

Authors
LM Rimsza;GL Wright;M Schwartz;J Chan;E Jaffe;R Gascoyne;E Campo;A Rosenwald;G Ott;J Cook;RR Tubbs;R Braziel;J Delabie;T Miller;RI Fisher;L Staudt
Journal / Conference
Blood 114:abst. #620, 2009 (ASH Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

High microvascular density correlates independently with poor outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus chemotherapy (R-CT)

Authors
T Cardesa;L Colomo;F Climent;E Gonzalez-Barca;G Gutierrez;M Mercadal;R Gascoyne;JM Connors;LM Rimsza;RM Braziel;J Cook;R Tubbs;A Rosenwald;G Ott;J Mate;J Ribera;L Arenillas;S Serrano;N Combalia;J Delabie;G Lenz;G Wright;E Jaffe;L Staudt;W Chan;D Weissenburger;A Lopez-Guillermo;E Campo
Journal / Conference
Blood 114:abst. #1948 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Chromosomal alterations in gene expression-defined pediatric aggressive B-cell non-hodgkin lymphomas (B-NHL)

Authors
K Deffenbacher;J Iqbal;Z Liu;S Perkins;M Lim;K Fu;J Shen;L Staudt;L Rimsza;E Jaffe;A Rosenwald;J Delabie;J Campo;R Gascoyne;D Weisenberger;T Greiner;TG Gross;W Chan
Journal / Conference
Blood 114 abst. #2922 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

MYC translocations and expression are clinically important in R-CHOP treated patients with de novo DLBCL

Authors
NA Johnson;S Ben-Neriah;KJ Savage;T Lee;DE Horsman;JM Connors;WC Chan;G Lenz;G Wright;L Rimsza;RM Braziel;J Cook;R Tubbs;D Weisenburger;E Campo;A Rosenwald;G Ott;J Delabie;E Jaffe;LM Staudt;RD Gascoyne
Journal / Conference
Blood 114:abst. 1100 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819